---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-092496"
form_type: "8-K"
ticker: "TRAW"
cik: "0001130598"
company_name: "Traws Pharma, Inc."
filed_at: "2024-08-23T23:59:59+00:00"
generated_at: "2026-05-31T07:48:00.792724+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Traws Pharma receives Nasdaq delisting notice for stockholders' deficit of $105.5M

## Summary
- Received Nasdaq letter on Aug 21, 2024 for non-compliance with minimum $2.5M stockholders' equity.
- Reported stockholders' deficit of $105.5M as of June 30, 2024, below the required minimum.
- Must submit a compliance plan by Oct 7, 2024; extension possible to Feb 18, 2025.
- No immediate effect on listing, but failure to regain compliance may lead to delisting.

## SEC filing metadata
- accession: 0001104659-24-092496
- form_type: 8-K
- ticker: TRAW
- cik: 0001130598
- company_name: Traws Pharma, Inc.
- filed_at: 2024-08-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130598/000110465924092496/0001104659-24-092496-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130598/000110465924092496/tm2422606d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-092496
- JSON: https://secwatch.observer/filing/0001104659-24-092496.json
- Plain text: https://secwatch.observer/filing/0001104659-24-092496.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.